ANI PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ani Pharmaceuticals Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q3 2024.
  • Ani Pharmaceuticals Inc Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $400K, unchanged year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $400K $0 0% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $400K $0 0% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $400K $0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $438K -$8K -1.79% Dec 31, 2023 10-K 2024-02-29
Q3 2023 $400K $0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $400K $0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $400K $0 0% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $446K -$4K -0.89% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $400K $0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $400K +$100K +33.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $400K +$100K +33.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $450K +$187K +71.1% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $400K $0 0% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $300K -$100K -25% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $300K Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $263K -$169K -39.1% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $400K Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $400K Jun 30, 2020 10-Q 2020-08-06
Q4 2019 $432K -$1.83M -80.9% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $2.27M +$1.94M +595% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $300K $0 0% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $300K $0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $300K $0 0% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $326K +$51K +18.5% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $300K +$100K +50% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $300K +$200K +200% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $300K +$200K +200% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $275K +$133K +93.7% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $200K +$100K +100% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $100K $0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $100K $0 0% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $142K $0 0% Dec 31, 2015 10-K 2017-03-02
Q3 2015 $100K Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $100K Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $100K Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $142K -$16.7M -99.2% Dec 31, 2014 10-K 2016-02-23
Q4 2013 $16.9M +$5.31M +45.9% Dec 31, 2013 10-K 2015-02-23
Q4 2012 $11.6M -$75M -86.6% Dec 31, 2012 10-K 2014-02-28
Q4 2011 $86.5M +$20.9M +31.8% Dec 31, 2011 10-K 2013-02-28
Q4 2010 $65.7M Dec 31, 2010 8-K 2013-01-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.